Sanju Narayanan

540 total citations
16 papers, 426 citations indexed

About

Sanju Narayanan is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Sanju Narayanan has authored 16 papers receiving a total of 426 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Cellular and Molecular Neuroscience and 7 papers in Pharmacology. Recurrent topics in Sanju Narayanan's work include Pharmacological Receptor Mechanisms and Effects (8 papers), Receptor Mechanisms and Signaling (6 papers) and Apelin-related biomedical research (5 papers). Sanju Narayanan is often cited by papers focused on Pharmacological Receptor Mechanisms and Effects (8 papers), Receptor Mechanisms and Signaling (6 papers) and Apelin-related biomedical research (5 papers). Sanju Narayanan collaborates with scholars based in United States, Belgium and India. Sanju Narayanan's co-authors include Christopher R. McCurdy, Christophe Mésangeau, Jacques H. Poupaert, Scott P. Runyon, Rangan Maitra, Debnath Bhuniya, Danni L. Harris, Sankar Mohan, Suryanarayana Vangapandu and Takato Hiranita and has published in prestigious journals such as Biological Psychiatry, The FASEB Journal and Journal of Medicinal Chemistry.

In The Last Decade

Sanju Narayanan

16 papers receiving 419 citations

Peers

Countries citing papers authored by Sanju Narayanan

Since Specialization

Citations

This map shows the geographic impact of Sanju Narayanan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sanju Narayanan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sanju Narayanan more than expected).

Fields of papers citing papers by Sanju Narayanan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sanju Narayanan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sanju Narayanan. The network helps show where Sanju Narayanan may publish in the future.

Co-authorship network of co-authors of Sanju Narayanan

This figure shows the co-authorship network connecting the top 25 collaborators of Sanju Narayanan. A scholar is included among the top collaborators of Sanju Narayanan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sanju Narayanan. Sanju Narayanan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Synthesis and characterization of an orally bioavailable small molecule agonist of the apelin receptor 2022 ·Bioorganic & Medicinal Chemistry ·Sanju Narayanan, (unknown), (unknown), (unknown), (unknown), (unknown), Stéphane Ciblat, (unknown), Scott P. Runyon, Rangan Maitra	5
2	Pyrazole Agonist of the Apelin Receptor Improves Symptoms of Metabolic Syndrome in Mice 2021 ·Journal of Medicinal Chemistry ·Sanju Narayanan, Shaobin Wang, (unknown), (unknown), (unknown), Chunyang Jin, Rodney W. Snyder, (unknown), Scott P. Runyon, Rangan Maitra	6
3	Identification of potent pyrazole based APELIN receptor (APJ) agonists 2019 ·Bioorganic & Medicinal Chemistry ·Sanju Narayanan, (unknown), Sudarshan Rajagopal, Rangan Maitra, Scott P. Runyon	13
4	Discovery of a novel small molecule agonist scaffold for the APJ receptor 2016 ·Bioorganic & Medicinal Chemistry ·Sanju Narayanan, Rangan Maitra, Jeffrey R. Deschamps, (unknown), James B. Thomas, Yanyan Zhang, (unknown), (unknown), Ann M. Decker, Scott P. Runyon	24
5	Blockade of Cocaine or σ Receptor Agonist Self Administration by Subtype-Selective σ Receptor Antagonists 2016 ·Journal of Pharmacology and Experimental Therapeutics ·Jonathan L. Katz, Takato Hiranita, Theresa Kopajtic, K.C. Rice, Christophe Mésangeau, Sanju Narayanan, Ahmed H. Abdelazeem, Christopher R. McCurdy	25
6	Regulation of the Apelinergic System and Its Potential in Cardiovascular Disease: Peptides and Small Molecules as Tools for Discovery 2015 ·Journal of Medicinal Chemistry ·Sanju Narayanan, Danni L. Harris, Rangan Maitra, Scott P. Runyon	41
7	Identification of N-{[6-chloro-4-(2,6-dimethoxyphenyl)quinazolin-2-yl]carbonyl}-l-leucine (NTRC-808), a novel nonpeptide chemotype selective for the neurotensin receptor type 2 2014 ·Bioorganic & Medicinal Chemistry Letters ·James B. Thomas, (unknown), O. Srinivas, Robert W. Wiethe, Danni L. Harris, Sanju Narayanan, (unknown), Philippe Sarret, Jean‐Michel Longpré, Scott P. Runyon, Brian P. Gilmour	5
8	Synthesis and Pharmacological Evaluation of 6-Acetyl-3-(4-(4-(4-fluorophenyl)piperazin-1-yl)butyl)benzo[d]oxazol-2(3H)-one (SN79), a Cocaine Antagonist, in Rodents 2011 ·The AAPS Journal ·Nidhi Kaushal, Matthew J. Robson, (unknown), Sanju Narayanan, Bonnie A. Avery, Christopher R. McCurdy, Rae R. Matsumoto	34
9	Sigma Receptors and Cocaine Abuse 2011 ·Current Topics in Medicinal Chemistry ·Sanju Narayanan, Christophe Mésangeau, Jacques H. Poupaert, Christopher R. McCurdy	31
10	Sigma Receptor Agonists: Receptor Binding and Effects on Mesolimbic Dopamine Neurotransmission Assessed by Microdialysis 2010 ·Biological Psychiatry ·Linda Garcés‐Ramírez, Jennifer L. Green, Takato Hiranita, Theresa Kopajtic, Maddalena Mereu, Alexandra M. Thomas, Christophe Mésangeau, Sanju Narayanan, Christopher R. McCurdy, Jonathan L. Katz, Gianluigi Tanda	78
11	Early Development of Sigma-Receptor Ligands 2010 ·Future Medicinal Chemistry ·Sanju Narayanan, (unknown), Christophe Mésangeau, Jacques H. Poupaert, Christopher R. McCurdy	42
12	Conversion of a Highly Selective Sigma-1 Receptor–Ligand to Sigma-2 Receptor Preferring Ligands with Anticocaine Activity 2008 ·Journal of Medicinal Chemistry ·Christophe Mésangeau, Sanju Narayanan, Andrea M. Green, Jamaluddin Shaikh, Nidhi Kaushal, (unknown), Yan‐Tong Xu, James A. Fishback, Jacques H. Poupaert, Rae R. Matsumoto, Christopher R. McCurdy	46
13	SN79, A Novel Sigma (σ) ‐ 2 Receptor Antagonist, Attenuates Cocaine‐Induced Behaviors In Mice 2008 ·The FASEB Journal ·Nidhi Kaushal, (unknown), Jamaluddin Shaikh, Sanju Narayanan, Christophe Mésangeau, Jacques H. Poupaert, Christopher R. McCurdy, Rae R. Matsumoto	3
14	Triphenylphosphine CatalyzedMichael Addition of Oximes onto Activated Olefins 2003 ·Synthesis ·Debnath Bhuniya, Sankar Mohan, Sanju Narayanan	32
15	Porcine Liver Esterase Catalyzed Kinetic Resolution of Baylis-Hillman (B-H) Adducts 2003 ·Synthetic Communications ·Debnath Bhuniya, Sanju Narayanan, (unknown), (unknown)	10
16	Regiospecific Synthesis of 2,3-Disubstituted-l-Histidines and Histamines 2001 ·Bioorganic & Medicinal Chemistry Letters ·Sanju Narayanan, Suryanarayana Vangapandu, Rahul Jain	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact